We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Kennametal
KMT
$2.3B
| $580K | ﹤0.01% |
24,630
-1,107
| -4% | -$27.2K |
|
1277
Southwest Gas
SWX
$6.31B
| $578K | ﹤0.01% |
8,218
+1,577
| +24% | +$118K |
|
1278
Agios Pharmaceuticals
AGIO
$2.04B
| $578K | ﹤0.01% |
13,394
+1,108
| +9% | +$40K |
|
1279
Grand Canyon Education
LOPE
$3.99B
| $578K | ﹤0.01% |
4,128
-234
| -5% | -$32.2K |
|
1280
CareDx
CDNA
$2.8B
| $575K | ﹤0.01% |
37,003
+2,536
| +7% | +$30.7K |
|
1281
Midland States Bancorp
MSBI
$699M
| $574K | ﹤0.01% |
25,357
-15,652
| -38% | -$360K |
|
1282
Hexcel
HXL
$6.73B
| $573K | ﹤0.01% |
9,181
-517
| -5% | -$34.7K |
|
1283
Option Care Health
OPCH
$3.57B
| $571K | ﹤0.01% |
20,621
+1,073
| +5% | +$32K |
|
|
EFOR
1284
Everforth Inc
EFOR
$1.31B
| $566K | ﹤0.01% |
6,424
-237
| -4% | -$22.6K |
|
1285
MakeMyTrip
MMYT
$4.5B
| $566K | ﹤0.01% |
6,730
-5,617
| -45% | -$419K |
|
1286
HEICO Corp Class A
HEI.A
$30.9B
| $566K | ﹤0.01% |
+3,186
| New | +$538K |
|
1287
Thor Industries
THO
$3.62B
| $565K | ﹤0.01% |
6,047
-265
| -4% | -$26.5K |
|
|
ETRN
1288
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $565K | ﹤0.01% |
43,530
-17,189
| -28% | -$231K |
|
1289
Newell Brands
NWL
$2.41B
| $564K | ﹤0.01% |
88,058
-1,413
| -2% | -$10.5K |
|
1290
First Citizens BancShares
FCNCA
$23.8B
| $564K | ﹤0.01% |
335
+188
| +128% | +$314K |
|
1291
Host Hotels & Resorts
HST
$15.1B
| $562K | ﹤0.01% |
31,257
-12,207
| -28% | -$228K |
|
1292
Genpact
G
$5.92B
| $561K | ﹤0.01% |
17,430
+52
| +0.3% | +$1.68K |
|
1293
James River Group Holdings
JRVR
$175M
| $561K | ﹤0.01% |
72,555
| – | – |
|
1294
Ennis
EBF
$543M
| $558K | ﹤0.01% |
25,469
-238
| -0.9% | -$4.89K |
|
1295
Freshworks
FRSH
$3.33B
| $555K | ﹤0.01% |
43,744
-609,783
| -93% | -$9.12M |
|
|
SCHW
1296
Charles Schwab
SCHW
$180B
| $554K | ﹤0.01% |
7,521
-113,286
| -94% | -$8.37M |
|
1297
Shake Shack
SHAK
$2.28B
| $552K | ﹤0.01% |
6,133
+1
| +0% | +$98 |
|
1298
Cable One
CABO
$103M
| $551K | ﹤0.01% |
1,556
-616
| -28% | -$236K |
|
1299
Cousins Properties
CUZ
$4.65B
| $545K | ﹤0.01% |
23,534
+501
| +2% | +$11.5K |
|
1300
Cullen/Frost Bankers
CFR
$9.93B
| $543K | ﹤0.01% |
5,343
-2,022
| -27% | -$212K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.